Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: Meta-analysis and meta-regression

Psychological Medicine

Volumn 45, Issue 3, 2015, Pages 453-465

  Velthorst, E ^a   Koeter, M ^a,b   Van Der Gaag, M ^b,c   Nieman, D H ^a   Fett, A K J ^a,d,e   Smit, F ^b,f   Staring, A B P ^g   Meijer, C ^a   De Haan, L ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^g Altrecht Psychiatric Institute   (Netherlands)

Author keywords

Cognitive behavioural therapy; psychosis; randomized controlled trials

Indexed keywords

COGNITIVE THERAPY; HUMAN; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; SCHIZOPHRENIA;

COGNITIVE THERAPY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; SCHIZOPHRENIA;

EID: 84927697164     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291714001147     Document Type: Article

References (60)

1. Arango C, Garibaldi G, Marder SR (2013). Pharmacological approaches to treating negative symptoms: a review of clinical trials. Schizophrenia Research 150, 346-352.
2. Baker A, Bucci S, Lewin TJ, Kay-Lambkin F, Constable PM, Carr VJ (2006). Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: randomised controlled trial. British Journal of Psychiatry 188, 439-448.
3. Barrowclough C, Haddock G, Lobban F, Jones S, Siddle R, Roberts C, Gregg L (2006). Group cognitive-behavioural therapy for schizophrenia. Randomised controlled trial. British Journal of Psychiatry 189, 527-532.
4. Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R, Schofield N, McGovern J (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry 158, 1706-1713.
5. Bechdolf A, Knost B, Kuntermann C, Schiller S, Klosterkötter J, Hambrecht M, Pukrop R (2004). A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica 110, 21-28.
6. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101.
7. Blanchard JJ, Kring AM, Horan WP, Gur R (2011). Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophrenia Bulletin 37, 291-299.
8. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009). Introduction to Meta-Analysis. Wiley: Chichester.
9. Cather C, Penn D, Otto MW, Yovel I, Mueser KT, Goff DC (2005). A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophrenia Research 74, 201-209.
10. Daniels L (1998). A group cognitive-behavioral and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research 7, 167-176.
11. Duval S, Tweedie R (2000). Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455-463.
12. Farhall J, Freeman NC, Shawyer F, Trauer T (2009). An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology 48, 47-62.
13. Gard DE, Kring AM, Gard MG, Horan WP, Green MF (2007). Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophrenia Research 93, 253-260.
14. Garety PA, Fowler DG, Freeman D, Bebbington P, Dunn G, Kuipers E (2008). Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. British Journal of Psychiatry 192, 412-423.
15. Gaudiano BA, Herbert JD (2006). Acute treatment of inpatients with psychotic symptoms using acceptance and commitment therapy: pilot results. Behaviour Research and Therapy 44, 415-437.
16. Granholm E, Ben-Zeev D, Link PC (2009). Social disinterest attitudes and group cognitive-behavioral social skills training for functional disability in schizophrenia. Schizophrenia Bulletin 35, 874-883.
17. Granholm E, Holden J, Link PC, McQuaid JR, Jeste DV (2013). Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry 21, 251-262.
18. Granholm E, McQuaid JR, McClure FS, Auslander LA, Perivoliotis D, Pedrelli P, Patterson T, Jeste DV (2005). A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry 162, 520-529.
19. Granholm E, McQuaid JR, McClure FS, Link PC, Perivoliotis D, Gottlieb JD, Patterson TL, Jeste DV (2007). Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry 68, 730-737.
20. Grant PM, Beck AT (2009). Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophrenia Bulletin 35, 798-806.
21. Grant PM, Huh GA, Perivoliotis D, Stolar NM, Beck AT (2012). Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Archives of General Psychiatry 69, 121-127.
22. Gumley A, O'Grady M, McNay L, Reilly J, Power KG, Norrie J (2003). Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine 33, 419-431.
23. Hall PL, Tarrier N (2003). The cognitive-behavioural treatment of low self-esteem in psychotic patients: a pilot study. Behaviour Research and Therapy 41, 317-332.
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed.) 327, 557-560.
25. Hjorthoj CR, Fohlmann A, Larsen AM, Gluud C, Arendt M, Nordentoft M (2013). Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine 43, 1499-1510.
26. Jackson HJ, McGorry PD, Killackey E, Bendall S, Allott K, Dudgeon P, Gleeson J, Johnson T, Harrigan S (2008). Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus befriending for first-episode psychosis: The ACE project. Psychological Medicine 38, 725-735.
27. Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR (2014). Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. British Journal of Psychiatry 204, 20-29.
28. Jones C, Hacker D, Cormac I, Meaden A, Irving CB (2012). Cognitive behavior therapy versus other psychosocial treatments for schizophrenia. Schizophrenia Bulletin 38, 908-910.
29. Kircanski K, Mazur H, Gotlib IH (2013). Behavioral activation system moderates self-referent processing following recovery from depression. Psychological Medicine 43, 1909-1919.
30. Kirkpatrick B, Castle D, Murray RM, Carpenter WT Jr (2000). Risk factors for the deficit syndrome of schizophrenia. Schizophrenia Bulletin 26, 233-242.
31. Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A, Marder SR (2011). The Brief Negative Symptom Scale: psychometric properties. Schizophrenia Bulletin 37, 300-305.
32. Klingberg S, Herrlich J, Wiedemann G, Wolwer W, Meisner C, Engel C, Jakobi-Malterre UE, Buchkremer G, Wittorf A (2012). Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the Treatment of Negative Symptoms study. Journal of Nervous and Mental Disease 200, 569-576.
33. Krakvik B, Grawe RW, Hagen R, Stiles TC (2013). Cognitive behaviour therapy for psychotic symptoms: a randomized controlled effectiveness trial. Behavioural and Cognitive Psychotherapy 41, 511-524.
34. Lecomte T, Leclerc C, Corbiere M, Wykes T, Wallace CJ, Spidel A (2008). Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous and Mental Disease 196, 866-875.
35. Lecomte T, Leclerc C, Wykes T (2012). Group CBT for early psychosis - are there still benefits one year later? International Journal of Group Psychotherapy 62, 309-321.
36. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373, 31-41.
37. Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, Siddle R, Drake R, Everitt J, Leadley K, Benn A, Grazebrook K, Haley C, Akhtar S, Davies L, Palmer S, Faragher B, Dunn G (2002). Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. British Journal of Psychiatry. Supplement 43, s91-s97.
38. Liemburg E, Castelein S, Stewart R, van der Gaag M, Aleman A, Knegtering H, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (2013). Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. Journal of Psychiatric Research 47, 718-725.
39. Lincoln TM, Ziegler M, Mehl S, Kesting ML, Lullmann E, Westermann S, Rief W (2012). Moving from efficacy to effectiveness in cognitive behavioral therapy for psychosis: a randomized clinical practice trial. Journal of Consulting and Clinical Psychology 80, 674-686.
40. Madigan K, Brennan D, Lawlor E, Turner N, Kinsella A, O'Connor JJ, Russell V, Waddington JL, O'Callaghan E (2013). A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research 143, 138-142.
41. National Institute for Clinical Excellence (2009). Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update). National Institute for Clinical Excellence: London.
42. Oorschot M, Lataster T, Thewissen V, Lardinois M, Wichers M, van Os J, Delespaul P, Myin-Germeys I (2013). Emotional experience in negative symptoms of schizophrenia - no evidence for a generalized hedonic deficit. Schizophrenia Bulletin 39, 217-225.
43. Penn DL, Meyer PS, Evans E, Wirth RJ, Cai K, Burchinal M (2009). A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research 109, 52-59.
44. Peters E, Landau S, McCrone P, Cooke M, Fisher P, Steel C, Evans R, Carswell K, Dawson K, Williams S, Howard A, Kuipers E (2010). A randomised controlled trial of cognitive behaviour therapy for psychosis in a routine clinical service. Acta Psychiatrica Scandinavica 122, 302-318.
45. Pinto A, La Pia S, Mennella R, Giorgio D, DeSimone L (1999). Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia. Psychiatric Services (Washington, D.C.) 50, 901-904.
46. Rathod S, Phiri P, Harris S, Underwood C, Thagadur M, Padmanabi U, Kingdon D (2013). Cognitive behaviour therapy for psychosis can be adapted for minority ethnic groups: a randomised controlled trial. Schizophrenia Research 143, 319-326.
47. Rector NA, Seeman MV, Segal ZV (2003). Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research 63, 1-11.
48. Saksa JR, Cohen SJ, Srihari VH, Woods SW (2009). Cognitive behavior therapy for early psychosis: a comprehensive review of individual vs. group treatment studies. International Journal of Group Psychotherapy 59, 357-383.
49. Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O'Carroll M, Barnes TR (2000). A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry 57, 165-172.
50. Shawyer F, Farhall J, Mackinnon A, Trauer T, Sims E, Ratcliff K, Larner C, Thomas N, Castle D, Mullen P, Copolov D (2012). A randomised controlled trial of acceptance-based cognitive behavioural therapy for command hallucinations in psychotic disorders. Behaviour Research and Therapy 50, 110-121.
51. Staring AB, Ter Huurne MA, van der Gaag M (2013). Cognitive behavioral therapy for negative symptoms (CBT-n) in psychotic disorders: a pilot study. Journal of Behavior Therapy and Experimental Psychiatry 44, 300-306.
52. Startup M, Jackson MC, Bendix S (2004). North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: outcomes at 6 and 12 months. Psychological Medicine 34, 413-422.
53. Sterk B, Winter van Rossum I, Muis M, de Haan L (2013). Priorities, satisfaction and treatment goals in psychosis patients: an online consumer's survey. Pharmacopsychiatry 46, 88-93.
54. Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Buchanan RW, Green MF, Carpenter WT Jr (2013). Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. Journal of Psychiatric Research 47, 783-790.
55. Tarrier N, Sommerfield C, Pilgrim H, Humphreys L (1999). Cognitive therapy or imaginal exposure in the treatment of post-traumatic stress disorder. Twelve-month follow-up. British Journal of Psychiatry 175, 571-575.
56. Tarrier N, Wykes T (2004). Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale? Behaviour Research and Therapy 42, 1377-1401.
57. Tarrier N, Yusupoff L, Kinney C, McCarthy E, Gledhill A, Haddock G, Morris J (1998). Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ (Clinical Research Ed.) 317, 303-307.
58. Turkington D, Sensky T, Scott J, Barnes TR, Nur U, Siddle R, Hammond K, Samarasekara N, Kingdon D (2008). A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up. Schizophrenia Research 98, 1-7.
59. Valmaggia LR, van der Gaag M, Tarrier N, Pijnenborg M, Slooff CJ (2005). Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry 186, 324-330.
60. Wykes T, Steel C, Everitt B, Tarrier N (2008). Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin 34, 523-537.